Which of the following is NOT true about infiximab:
- a- IL-1 blocker
- b- used for treatment of severe rheumatoid arthritis
- c- may increase risk of infections
- d- administered as IV infusione-postadministration reactions include fever & chills.
The statement that is not true about infliximab is a- IL-1 blocker.
Infliximab is a tumor necrosis factor (TNF) alpha inhibitor, not an IL-1 blocker. TNF-alpha is a cytokine that plays a role in inflammation. Infliximab works by blocking the activity of TNF-alpha, which can help to reduce inflammation and tissue damage.
The other statements about infliximab are all true:
b- Used for treatment of severe rheumatoid arthritis:
Infliximab is a biologic medication that is used to treat severe rheumatoid arthritis that has not responded to other treatments.
c- May increase risk of infections:
Infliximab can increase the risk of infections, including serious infections such as tuberculosis.
d- Administered as IV infusion-postadministration reactions include fever & chills:
Infliximab is administered as an intravenous (IV) infusion. Post-administration reactions to infliximab can include fever, chills, headache, and nausea.
Labels
pharmacology